The presentation began with Mark MacDonald introducing EuroAPI, highlighting its six manufacturing sites in Europe, over 3,500 employees, and headquarters in Paris. EuroAPI's CDMO business included around 200 catalogue APIs, with sales and distribution in more than 80 countries. MacDonald detailed the various manufacturing facilities, including spray drying in the UK, fermentation sites in France and Italy, and API manufacturing in Budapest and Germany. He emphasised the long-standing history of EuroAPI's sites, some dating back over 150 years.
MacDonald discussed EuroAPI's structured platform perspective within R&D, covering small molecules, high potent APIs, peptides, oligonucleotides, and biotechnology. He stressed the importance of reliability, quality, and business continuity in their processes. He also touched on EuroAPI's ESG initiatives, including their EcoVadis silver rating and efforts to achieve 100% renewable electricity by 2025.
Kerstin Hofmann then took over, focusing on the scientific aspects of EuroAPI's work. She mentioned the company's recent entry into the CDMO market and its long history, including peptide synthesis since 1976 and oligonucleotide synthesis since 2003. Hofmann highlighted EuroAPI's commercial product, Lixisenatide, and their work on Mipomersen, an oligonucleotide. She detailed the synthesis platforms used for peptides and oligonucleotides, including CS bio and Pepti systems.
Hofmann discussed EuroAPI's investment in downstream equipment and clean room areas, aiming to purify batches for customers by the end of the year. She emphasised the company's analytical capabilities, including method development and validation. Hofmann also highlighted EuroAPI's experience in small molecules, peptides, and oligonucleotides, offering a one-stop-shop for clients.
The presentation concluded with Hofmann discussing EuroAPI's innovation efforts, including green chemistry, conjugation modalities, and purification methods. She stressed the company's strong R&D capabilities, quality systems, and customer service.